AlphaYouLXEO: Bhalla Narinder Pal discloses securities transactions
By AlphaYouPublished Form 4
Bhalla Narinder Pal
Reporting filer
Bhalla Narinder Pal reported Grant or award in Lexeo Therapeutics, Inc.: 2714 units of Common Stock, dated 2026-09-14. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 28, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Bhalla Narinder Pal | 2026-09-14 | A | Grant or award | 2714 | 3.579 | 84,908 | 14 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Bhalla Narinder Pal | 2026-09-24 | A | Grant or award | 54750 | 0 | 54,750 | 4 days | Filed terms
|
Common Stock
- Owner
- Bhalla Narinder Pal
- Date
- 2026-09-14
- Code
- A
- Action
- Grant or award
- Quantity
- 2714
- Price
- 3.579
- Following holdings
- 84,908
- Reporting delay
- 14 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-14
- transaction Form Type: 5
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 2714
- id: F1
- transaction Price Per Share: 3.579
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 84908
- id: F2
- direct Or Indirect Ownership: D
- nature Of Ownership:
Stock Option (right to buy) (derivative)
- Owner
- Bhalla Narinder Pal
- Date
- 2026-09-24
- Code
- A
- Action
- Grant or award
- Quantity
- 54750
- Price
- 0
- Following holdings
- 54,750
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 3.39
- transaction Date: 2026-09-24
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 54750
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- expiration Date: 2036-09-23
- underlying Security Title: Common Stock
- underlying Security Shares: 54750
- shares Owned Following Transaction: 54750
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bhalla Narinder Pal: Chief Medical Officer.
- F1: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- F2: Includes 49,500 Restricted Stock Units.
- F3: 25% of the shares underlying the option vest and become exercisable on September 24, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
Original sources
Prepared automatically from public filing data. Report a correction.